LINC01235 Promotes Clonal Evolution through DNA Replication Licensing‐Induced Chromosomal Instability in Breast Cancer

Abstract Despite the development of HER2‐targeting drugs such as trastuzumab and T‐DXd, treatment resistance is a substantial challenge, often leading to relapse and distant metastasis. Tumor heterogeneity in HER2‐positive breast cancer drives the evolution of resistant clones following therapeutic...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Qi Zhang, Xuliren Wang, Zhibo Shao, Yi Zhang, Liyi Zhang, Ming Chen, Xujie Zhou, Han Zhu, Yue Zhou, Xinya Lu, Pei Li, Weiru Chi, Lun Li, Zhi‐Ming Shao, Shenglin Huang, Jingyan Xue, Yayun Chi, Jiong Wu, Bingqiu Xiu
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Wiley 2025-04-01
Edice:	Advanced Science
Témata:	ATR inhibitors chromosomal instabilities DNA replication licensing HER2‐positive breast cancers LINC01235
On-line přístup:	https://doi.org/10.1002/advs.202413527
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!